THERIANA PHARMACEUTICALS
THERIANA PHARMACEUTICALS
Industry:
Biotechnology Health Care Manufacturing Pharmaceutical
Founded:
2017-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
781-795-4723
Total Funding:
1.75 M USD
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
More informations about "Theriana Pharmaceuticals"
Theriana Pharmaceuticals - PitchBook
Theriana Pharmaceuticals General Information Description. Operator of a biotechnology company. The company is dedicated to the acquisition and expert development of new โฆSee details»
Theriana Pharmaceuticals - Funding, Financials, Valuation
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jul 5, 2017: Venture Round - โฆSee details»
THERIANA PHARMACEUTICALS, INC. - Bizapedia
Apr 10, 2024 THERIANA PHARMACEUTICALS, INC. is a Massachusetts Foreign Corporation filed on February 21, 2017. The company's File Number is listed as 001261501. The โฆSee details»
Theriana Pharmaceuticals - Products, Competitors, Financials, โฆ
Headquarters Location. 890 Winter Street Suite 315. Waltham, Massachusetts, 02451, United States. 781-795-4723See details»
THERIANA PHARMACEUTICALS, INC. :: Massachusetts (US)
Free and open company data on Massachusetts (US) company THERIANA PHARMACEUTICALS, INC. (company number 001261501), 890 WINTER ST., STE 315, โฆSee details»
Theriana Pharmaceuticals - Crunchbase
Theriana Pharmaceuticals, Inc. manufactures pharmaceuticals. Start Free Trial . Chrome ExtensionSee details»
Theriana Pharmaceuticals - VentureRadar
CURE Pharmaceutical USA n/a CURE Pharmaceutical is the pioneering developer of CUREformโข, a patented drug delivery platform that offers a number of unique immediate- and โฆSee details»
Theriana Pharmaceuticals Stock Price, Funding, Valuation, Revenue ...
See Theriana Pharmaceuticals funding rounds, investors, investments, exits and more. Evaluate their financials based on Theriana Pharmaceuticals's post-money valuation and revenue.See details»
Daniel S. Grau: Positions, Relations and Network - MarketScreener
Daniel S. Grau was the founder of Sojournix, Inc. founded in 2016, where he held the title of President, Chief Executive Officer & Director. Currently, he holds multiple positions as โฆSee details»
Theranos - Wikipedia
Theranos Inc. (/ ห ฮธ ษr. ษ n. oส s /) was an American privately held corporation [5] that was touted as a breakthrough health technology company. Founded in 2003 by then 19-year-old Elizabeth Holmes, Theranos raised more than US$700 โฆSee details»
Daniel S. Grau: Positions, Relations and Network - MarketScreener
Chief Executive Officer at Theriana Pharmaceuticals, Inc., Discover Daniel S. Grau's known position history, network and 45 relationships. Find out about his known public assets. โฆSee details»
Theriana Pharmaceuticals Culture | Comparably
Learn about Theriana Pharmaceuticals' culture, see what work's like, read reviews, and find job opportunities.See details»
Venture Round - Theriana Pharmaceuticals - 2017-07-05
Organization Name . Theriana Pharmaceuticals . Announced Date Jul 5, 2017; Funding Type ...See details»
Daniel S. Grau - MarketScreener.com
Find out more about Daniel S. Grau's international, operational and industry experience. 13 positions known in addition to Chief Executive Officer at Theriana Pharmaceuticals, Inc. โฆSee details»
TheraRNA Company Profile 2024: Valuation, Funding & Investors
TheraRNA General Information Description. Developer and research of mRNA vaccine drugs designed to cure infectious diseases and cancers. The company's drugs focus on mRNA anti โฆSee details»
Made-in-Canada COVID vaccine to be manufactured in Calgary
Jan 26, 2021 Last week, Next Generation Manufacturing Canada (NGen), the industry-led organization behind Canadaโs Advanced Manufacturing Supercluster, announced it would โฆSee details»
Therakann Pharmaceuticals - Cannabis Industry Council
We offer a wide variety of products and services in cannabis industry with a vast knowledge of the market of pharmaceutical treatment and clinical research on cannabinoids. Our company โฆSee details»
THERANICA: Expands Executive Team Amid Growing US Demand โฆ
May 19, 2020 Theranica issued the following announcement on May 18. Theranica USA, a fully owned subsidiary of Theranica Bioelectronics (Theranica), a bio-medical technology company โฆSee details»
FDA Approves Theranica's Nerivio® for Acute Treatment of โฆ
Jan 25, 2021 10% of all school age children and up to 28% of teens between the ages of 15-19 live with migraine. 37% of children find that their schoolwork suffers during a headache and it โฆSee details»